Designing Evidence-Based Preventive Interventions That Reach More People, Faster, and with More Impact in Global Contexts.

Annual Review of Clinical Psychology
Mary Jane Rotheram-Borus

Abstract

This article demonstrates the substantial similarities globally among preventive, evidence-based interventions (EBIs) designed to address HIV by providing four examples: an HIV family-focused intervention, the Community Popular Opinion Leader intervention, a South African maternal/child health program, and an EBI for sex workers in India. Each identified the key problems in the target population, utilized well-established social cognitive theories, created processes for engaging the target population, set standards for staff accountability, and included routine data collection to facilitate iterative program improvements over time. Building EBIs based on these common, robust features is an alternative design strategy to replication with fidelity. These components provide a road map for researchers, especially those using new technologies, and for local providers seeking to deliver EBIs that match their clients' and communities' needs. Technology platforms and community organizations may serve as resources for designers of the next generation of EBIs, offering an alternative to repeatedly validating the same interventions and replicating them with fidelity.

References

Mar 1, 1971·Psychophysiology·L F Van EgerenP L Hein
Feb 1, 1993·Hospital & Community Psychiatry·J G RabkinJ B Williams
Mar 1, 1997·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·M J Rotheram-BorusM Gwadz
May 20, 1998·Family Process·M J Rotheram-BorusB H Draimin
Mar 10, 2001·American Journal of Public Health·M J Rotheram-BorusUNKNOWN Teens Linked to Care Consortium
Mar 17, 2001·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·M J Rotheram-BorusUNKNOWN Teens Linked to Care Consortium
Nov 1, 1961·Journal of Abnormal and Social Psychology·A BANDURAS A ROSS
May 1, 1964·Behaviour Research and Therapy·J WOLPE, P J LANG
Jun 24, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ishika BasuRobert Weiss
Jul 14, 2004·American Journal of Public Health·Steven L West, Keri K O'Neal
Jul 30, 2004·Social Work·Samuel A MacMaster
Aug 4, 2004·Archives of Pediatrics & Adolescent Medicine·Mary Jane Rotheram-BorusPatricia Lester
Sep 24, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mary Jane Rotheram-BorusMarguerita Lightfoot
Oct 20, 2004·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Smarajit JanaPeter A Newman
Oct 27, 2004·Lancet·Stanton NewmanKathleen Mulligan
Jan 5, 2005·Annals of Internal Medicine·Adam Gilden Tsai, Thomas A Wadden
Jan 6, 2005·JAMA : the Journal of the American Medical Association·Michael L DansingerErnst J Schaefer
Mar 31, 2005·Journal of Consulting and Clinical Psychology·Mary Jane Rotheram-BorusPatricia Lester
Dec 21, 2005·Prevention Science : the Official Journal of the Society for Prevention Research·Brian R FlayPeter Ji
Jul 1, 2006·American Journal of Public Health·Don C Des JarlaisNaomi Braine
Jul 11, 2006·Journal of Consulting and Clinical Psychology·Mary Jane Rotheram-BorusLynwood Lord
Jul 7, 2007·The American Journal of Drug and Alcohol Abuse·W Scott ComuladaMary Jane Rotheram-Borus
Sep 12, 2007·Prevention Science : the Official Journal of the Society for Prevention Research·Marguerita A LightfootMary Jane Rotheram-Borus
Mar 12, 2008·AIDS and Behavior·Barbara L IngramMary Jane Rotheram-Borus
Sep 11, 2008·Health Affairs·Jason Hwang, Clayton M Christensen
Sep 19, 2008·American Journal of Public Health·Mary Jane Rotheram-BorusUNKNOWN Healthy Living Trial Group
Oct 3, 2008·AIDS and Behavior·Mary Jane Rotheram-BorusBarbara Ingram
Feb 19, 2009·AIDS and Behavior·Mary Jane Rotheram-BorusDiane Flannery
May 15, 2009·International Journal of Environmental Research and Public Health·Wei Pan, Haiyan Bai
Sep 1, 2009·Social Science & Medicine·Dallas SwendemanMary Jane Rotheram-Borus
Dec 22, 2009·AIDS Care·Dallas SwendemanMary Jane Rotheram-Borus
Feb 25, 2010·AIDS·Nancy S PadianJudith N Wasserheit
Apr 1, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·UNKNOWN NIMH Collaborative HIV/STD Prevention Trial Group
Sep 9, 2010·Annual Review of Psychology·Irwin N SandlerDavid P MacKinnon
Feb 1, 2011·Sexually Transmitted Infections·Mary Jane Rotheram-BorusUNKNOWN NIMH Collaborative HIV/STD Prevention Trial Group
Aug 19, 2011·Prevention Science : the Official Journal of the Society for Prevention Research·Mary Jane Rotheram-BorusDallas Swendeman
Oct 25, 2011·AIDS and Behavior·Mary Jane Rotheram-BorusEna Valladares

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Prevention Science : the Official Journal of the Society for Prevention Research
Abigail A FaganDeborah Klein Walker
Health Education & Behavior : the Official Publication of the Society for Public Health Education
Rogério M PintoMelanie Wall
Health Education & Behavior : the Official Publication of the Society for Public Health Education
Jennifer LeemanMaría E Fernández
© 2021 Meta ULC. All rights reserved